GlassScriptPhysician profile
Robert T Perkins
NPI 1366892416
$2,373.73
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $63.34 · 2021: $946 · 2022: $1,138 · 2024: $26.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $853.53 | 2020-2022 | |
| Novo Nordisk INC | $196.60 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.62 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $147.68 | 2022 | |
| Glaxosmithkline, LLC. | $143.38 | 2019-2022 | |
| Lilly USA, LLC | $139.66 | 2019-2022 | |
| Amgen INC. | $139.62 | 2019-2022 | |
| Pfizer INC. | $79.89 | 2021-2022 | |
| Agile Therapeutics, INC. | $42.31 | 2021 | |
| Radius Health, INC. | $32.96 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $26.00 | 2024 | |
| Millicent US INC | $24.69 | 2019 | |
| Idorsia Pharmaceuticals US INC | $22.71 | 2022 | |
| Abbott Laboratories | $21.78 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.48 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.23 | 2021 | |
| Kaleo, INC. | $17.15 | 2019 | |
| Therapeuticsmd, INC. | $16.99 | 2020 | |
| Philips North America LLC | $15.13 | 2020 | |
| Allergan, INC. | $14.95 | 2019 | |
| Circassia INC. | $13.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.16 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.